What is Raymond James's price target for CDRE?

Raymond James's latest stated price target for Cadre Holdings Inc. (CDRE) is $27, from its action on Mar 11, 2022.

What is Raymond James's rating on CDRE?

Raymond James rates CDRE Mkt Perform, a neutral rating, as of Jan 22, 2024.

When did Raymond James last change its view on CDRE?

On Jan 22, 2024, Raymond James downgrades to Mkt Perform from Outperform.

Raymond James CDRE price target and rating history

Cadre Holdings Inc. (CDRE) · Health Care

Raymond James rates Cadre Holdings Inc. (CDRE) Mkt Perform with a $27 price target, as of its latest action on Jan 22, 2024. It has published 3 rating actions on CDRE since November 2021, including 0 upgrades and 1 downgrade.

Current rating: Mkt Perform
Price target: $27
Median target, all firms: Too few
Actions on CDRE: 3

Raymond James price target on CDRE

Raymond James price target on CDRE, each point a stated target, November 2021 to March 2022.

Every Raymond James rating on CDRE

Jan 22, 2024
DowngradeRaymond James downgrades to Mkt Perform from Outperform
Mar 11, 2022
ReiterateRaymond James raises its price target to $27 from $25, keeps Outperform
Nov 29, 2021
InitiateRaymond James starts coverage at Outperform, price target $25

Questions about Raymond James and CDRE

What is Raymond James's price target for CDRE?: Raymond James's latest stated price target for Cadre Holdings Inc. (CDRE) is $27, from its action on Mar 11, 2022.
What is Raymond James's rating on CDRE?: Raymond James rates CDRE Mkt Perform, a neutral rating, as of Jan 22, 2024.
When did Raymond James last change its view on CDRE?: On Jan 22, 2024, Raymond James downgrades to Mkt Perform from Outperform.

More CDRE rating histories

BofA Securities3

All Raymond James ratings CDRE news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.